Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OSPEMIFENE vs OXITRIPTAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

OSPEMIFENE vs OXITRIPTAN: Safety Overview

Metric OSPEMIFENE OXITRIPTAN
Total FAERS Reports 2,047 100
Deaths Reported 2 5
Death Rate 0.1% 5.0%
Hospitalizations 60 34
Average Patient Age 61.7 yrs 52.2 yrs
% Female Patients 99.8% 58.6%
FDA Approval Date Feb 13, 2024 N/A
Manufacturer Duchesnay USA, Inc. Energique, Inc.
Route ORAL ORAL
Marketing Status Prescription N/A